Allarity Therapeutics Refocuses Oncology Pipeline Strategy Towards Combination Therapies

Go back to Allarity Therapeutics Refocuses Oncology Pipeline Strategy Towards Combination Therapies
(NASDAQ: ALLR) Delayed: 1.37 -0.05 (3.52%)
Previous Close $1.42    52 Week High
Open $1.42    52 Week Low
Day High $1.42    P/E N/A 
Day Low $1.37    EPS
Volume 13,562